Amy Harlow

2.2k total citations · 1 hit paper
10 papers, 1.6k citations indexed

About

Amy Harlow is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Hematology. According to data from OpenAlex, Amy Harlow has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 4 papers in Hematology. Recurrent topics in Amy Harlow's work include Sarcoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Amy Harlow is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Amy Harlow collaborates with scholars based in United States, Canada and Netherlands. Amy Harlow's co-authors include Michael C. Heinrich, Christopher L. Corless, Ajia Town, Jonathan A. Fletcher, Arin McKinley, George D. Demetri, Claudia Le, Christopher D.�M. Fletcher, Robert G. Maki and Diana Griffith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Amy Harlow

10 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

2008 564 citations Michael C. Heinrich, Robert G. Maki et al. Journal of Clinical Oncology profile →

Peers

Amy Harlow

PRM

GASTR

ONCOL

MB

SURGE

Nicole Mentens Belgium

Stefan Dirnhofer Switzerland

Claudia Le United States

Troy Bainbridge United States

Rodrigo Ruiz‐Soto United States

Arin McKinley United States

Marc Martens Belgium

W. Ruka Poland

Gina Z. D’Amato United States

Zbigniew Nowecki Poland

Nicole Mentens Belgium

Amy Harlow

619 ×0.9

PRM

480 ×0.8

GASTR

449 ×0.8

ONCOL

766 ×1.7

MB

263 ×1.0

SURGE

Citations per year, relative to Amy Harlow Amy Harlow (= 1×) peers Nicole Mentens

Countries citing papers authored by Amy Harlow

Since Specialization

Citations

This map shows the geographic impact of Amy Harlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Harlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Harlow more than expected).

Fields of papers citing papers by Amy Harlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Harlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Harlow. The network helps show where Amy Harlow may publish in the future.

Co-authorship network of co-authors of Amy Harlow

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Harlow. A scholar is included among the top collaborators of Amy Harlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Harlow. Amy Harlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Beadling, Carol, Michael C. Heinrich, Andrea Warrick, et al.. (2011). Multiplex Mutation Screening by Mass Spectrometry. Journal of Molecular Diagnostics. 13(5). 504–513. 55 indexed citations

2.

Schittenhelm, Marcus M., Christian Kollmannsberger, Karin Oechsle, et al.. (2009). Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer. Molecular Cancer Therapeutics. 8(3). 481–489. 15 indexed citations

3.

Heinrich, Michael C., Robert G. Maki, Christopher L. Corless, et al.. (2008). Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 26(33). 5352–5359. 564 indexed citations breakdown →

4.

Heinrich, Michael C., Heikki Joensuu, George D. Demetri, et al.. (2008). Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases. Clinical Cancer Research. 14(9). 2717–2725. 151 indexed citations

5.

Hess, Corine J., N Feller, Fedor Denkers, et al.. (2008). Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia. Haematologica. 94(1). 46–53. 12 indexed citations

6.

Beadling, Carol, Erick Jacobson‐Dunlop, F. Stephen Hodi, et al.. (2008). KIT Gene Mutations and Copy Number in Melanoma Subtypes. Clinical Cancer Research. 14(21). 6821–6828. 491 indexed citations

7.

Janeway, Katherine A., Bernadette Liegl, Amy Harlow, et al.. (2007). Pediatric KIT –Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors. Cancer Research. 67(19). 9084–9088. 114 indexed citations

8.

Heinrich, Michael C., Christopher L. Corless, Bernadette Liegl, et al.. (2007). Mechanisms of sunitinib malate (SU) resistance in gastrointestinal stromal tumors (GISTs). Journal of Clinical Oncology. 25(18_suppl). 10006–10006. 14 indexed citations

9.

Agarwal, Anupriya, Christopher A. Eide, Amy Harlow, et al.. (2007). An Activating KRAS Mutation in Imatinib Resistant Chronic Myeloid Leukemia.. Blood. 110(11). 1006–1006. 1 indexed citations

10.

Goemans, Bianca F., Ch. M. Zwaan, M Zimmermann, et al.. (2005). Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia. 19(9). 1536–1542. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact